SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:6eb42767-a3a8-46f7-b9e3-5b36a41d7665"
 

Search: onr:"swepub:oai:lup.lub.lu.se:6eb42767-a3a8-46f7-b9e3-5b36a41d7665" > Improving the Devel...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Improving the Developability of an Antigen Binding Fragment by Aspartate Substitutions

Sakhnini, Laila I (author)
Lund University,Lunds universitet,Tillämpad biokemi,Centrum för tillämpade biovetenskaper,Kemiska institutionen,Institutioner vid LTH,Lunds Tekniska Högskola,Pure and Applied Biochemistry,Center for Applied Life Sciences,Department of Chemistry,Departments at LTH,Faculty of Engineering, LTH,Novo Nordisk A/S
Greisen, Per J (author)
Novo Nordisk A/S
Wiberg, Charlotte (author)
Novo Nordisk A/S
show more...
Bozoky, Zoltan (author)
Novo Nordisk A/S
Lund, Søren (author)
Novo Nordisk A/S
Wolf Perez, Adriana-Michelle (author)
Novo Nordisk A/S
Karkov, Hanne S (author)
Novo Nordisk A/S
Huus, Kasper (author)
Novo Nordisk A/S
Hansen, Jens-Jacob (author)
Novo Nordisk A/S
Bülow, Leif (author)
Lund University,Lunds universitet,Tillämpad biokemi,Centrum för tillämpade biovetenskaper,Kemiska institutionen,Institutioner vid LTH,Lunds Tekniska Högskola,Pure and Applied Biochemistry,Center for Applied Life Sciences,Department of Chemistry,Departments at LTH,Faculty of Engineering, LTH
Lorenzen, Nikolai (author)
Novo Nordisk A/S
Dainiak, Maria B (author)
Novo Nordisk A/S
Pedersen, Anja K (author)
Novo Nordisk A/S
show less...
 (creator_code:org_t)
2019-05-22
2019
English.
In: Biochemistry. - : American Chemical Society (ACS). - 0006-2960 .- 1520-4995. ; 58:24, s. 2750-2759
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Aggregation can be a major challenge in the development of antibody-based pharmaceuticals as it can compromise the quality of the product during bioprocessing, formulation, and drug administration. To avoid aggregation, developability assessment is often run in parallel with functional optimization in the early screening phases to flag and deselect problematic molecules. As developability assessment can be demanding with regard to time and resources, there is a high focus on the development of molecule design strategies for engineering molecules with a high developability potential. Previously, Dudgeon et al. [(2012) Proc. Natl. Acad. Sci. U. S. A. 109, 10879-10884] demonstrated how Asp substitutions at specific positions in human variable domains and single-chain variable fragments could decrease the aggregation propensity. Here, we have investigated whether these Asp substitutions would improve the developability potential of a murine antigen binding fragment (Fab). A full combinatorial library consisting of 393 Fab variants with single, double, and triple Asp substitutions was first screened in silico with Rosetta; thereafter, 26 variants with the highest predicted thermodynamic stability were selected for production. All variants were subjected to a set of developability studies. Interestingly, most variants had thermodynamic stability on par with or improved relative to that of the wild type. Twenty-five of the variants exhibited improved nonspecificity. Half of the variants exhibited improved aggregation resistance. Strikingly, while we observed remarkable improvement in the developability potential, the Asp substitutions had no substantial effect on the antigenic binding affinity. Altogether, by combining the insertion of negative charges and the in silico screen based on computational models, we were able to improve the developability of the Fab rapidly.

Subject headings

NATURVETENSKAP  -- Biologi -- Biokemi och molekylärbiologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Biochemistry and Molecular Biology (hsv//eng)

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view